Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation
(2011) In Blood 118(13). p.3613-3621- Abstract
- Acquisition of homozygous activating growth factor receptor mutations might accelerate cancer progression through a simple gene-dosage effect. Internal tandem duplications (ITDs) of FLT3 occur in approximately 25% cases of acute myeloid leukemia and induce ligand-independent constitutive signaling. Homozygous FLT3-ITDs confer an adverse prognosis and are frequently detected at relapse. Using a mouse knockin model of Flt3-internal tandem duplication (Flt3-ITD)-induced myeloproliferation, we herein demonstrate that the enhanced myeloid phenotype and expansion of granulocyte-monocyte and primitive Lin(-)Sca1(+)c-Kit(+) progenitors in Flt3-ITD homozygous mice can in part be mediated through the loss of the second wild-type allele. Further,... (More)
- Acquisition of homozygous activating growth factor receptor mutations might accelerate cancer progression through a simple gene-dosage effect. Internal tandem duplications (ITDs) of FLT3 occur in approximately 25% cases of acute myeloid leukemia and induce ligand-independent constitutive signaling. Homozygous FLT3-ITDs confer an adverse prognosis and are frequently detected at relapse. Using a mouse knockin model of Flt3-internal tandem duplication (Flt3-ITD)-induced myeloproliferation, we herein demonstrate that the enhanced myeloid phenotype and expansion of granulocyte-monocyte and primitive Lin(-)Sca1(+)c-Kit(+) progenitors in Flt3-ITD homozygous mice can in part be mediated through the loss of the second wild-type allele. Further, whereas autocrine FLT3 ligand production has been implicated in FLT3-ITD myeloid malignancies and resistance to FLT3 inhibitors, we demonstrate here that the mouse Flt3(ITD/ITD) myeloid phenotype is FLT3 ligand-independent. (Blood. 2011; 118(13):3613-3621) (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/2179667
- author
- organization
-
- Stem Cell Center
- Department of Translational Medicine
- Division of Molecular Hematology (DMH)
- Lymphoid Development and Regulation (research group)
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- publishing date
- 2011
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Blood
- volume
- 118
- issue
- 13
- pages
- 3613 - 3621
- publisher
- American Society of Hematology
- external identifiers
-
- wos:000295359300027
- pmid:21813452
- scopus:80053348990
- pmid:21813452
- ISSN
- 1528-0020
- DOI
- 10.1182/blood-2010-06-289207
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Stem Cell Center (013041110), Hematology/Transplantation (013022014), Experimental Clinical Chemistry (013016010)
- id
- 176cf1cc-a519-4061-bb23-e3fa53bb9f31 (old id 2179667)
- date added to LUP
- 2016-04-01 10:24:09
- date last changed
- 2022-02-10 01:43:29
@article{176cf1cc-a519-4061-bb23-e3fa53bb9f31, abstract = {{Acquisition of homozygous activating growth factor receptor mutations might accelerate cancer progression through a simple gene-dosage effect. Internal tandem duplications (ITDs) of FLT3 occur in approximately 25% cases of acute myeloid leukemia and induce ligand-independent constitutive signaling. Homozygous FLT3-ITDs confer an adverse prognosis and are frequently detected at relapse. Using a mouse knockin model of Flt3-internal tandem duplication (Flt3-ITD)-induced myeloproliferation, we herein demonstrate that the enhanced myeloid phenotype and expansion of granulocyte-monocyte and primitive Lin(-)Sca1(+)c-Kit(+) progenitors in Flt3-ITD homozygous mice can in part be mediated through the loss of the second wild-type allele. Further, whereas autocrine FLT3 ligand production has been implicated in FLT3-ITD myeloid malignancies and resistance to FLT3 inhibitors, we demonstrate here that the mouse Flt3(ITD/ITD) myeloid phenotype is FLT3 ligand-independent. (Blood. 2011; 118(13):3613-3621)}}, author = {{Kharazi, Shabnam and Mead, Adam J. and Mansour, Anna and Hultquist, Anne and Böiers, Charlotta and Luc, Sidinh and Buza-Vidas, Natalija and Ma, Zhi and Ferry, Helen and Atkinson, Debbie and Reckzeh, Kristian and Masson, Kristina and Cammenga, Jörg and Rönnstrand, Lars and Arai, Fumio and Suda, Toshio and Nerlov, Claus and Sitnicka Quinn, Ewa and Jacobsen, Sten Eirik W}}, issn = {{1528-0020}}, language = {{eng}}, number = {{13}}, pages = {{3613--3621}}, publisher = {{American Society of Hematology}}, series = {{Blood}}, title = {{Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation}}, url = {{http://dx.doi.org/10.1182/blood-2010-06-289207}}, doi = {{10.1182/blood-2010-06-289207}}, volume = {{118}}, year = {{2011}}, }